Current market catalysts

Structure Therapeutics Advances Weight-Loss Pills With New Clinical Data

Structure Therapeutics (NASDAQ: GPCR) reports strong clinical trial data for oral weight loss candidates ACCG-2671 and aleniglipron.

3 Insurers to Watch as Competition in Personal Auto Intensifies

The U.S. personal auto insurance industry is transitioning from a rate-increase phase to competitive growth as loss ratios improve. Leading insurers with superior underwriting, technology, and distribution capabilities are positioned to gain market share and sustain profitability. The Travelers, Allstate, and Progressive are well-positioned to benefit from this shift, though competitive pricing may moderate industry-wide returns.

Verastem Stock Skyrockets 121% in 3 Months: Here Is Why

Verastem (VSTM) shares have surged 121% over three months, driven by accelerating sales of ovarian cancer drug Avmapki Fakzynja Co-Pack, which generated $25.1 million in Q2 2026 revenues (up 1,095% YoY), and growing optimism around VS-7375, a KRAS G12D inhibitor in phase II trials across pancreatic, lung, and colorectal cancers. The company expects VS-7375 data in October 2026 and plans FDA meetings before year-end to discuss phase III pivotal trial designs.

The Zacks Analyst Blog Highlights FANUY, ABBNY, KYCCF, NVDA, ISRG, ILMN, NOVT, BOTZ, ROBO, ROBT and IBOT

Zacks highlights the robotics and AI sector as a major growth opportunity, with the general-purpose robotics market projected to grow from under $1 billion in 2025 to $370 billion by 2040. The article examines key industry players including Fanuc, ABB, Keyence, NVIDIA, Intuitive Surgical, and Illumina, and recommends four robotics-focused ETFs (BOTZ, ROBO, ROBT, IBOT) as diversified investment vehicles to capitalize on this trend.

Robinhood Enters IPO Underwriting: Can IB Be the Next Growth Avenue?

Robinhood Markets has joined the underwriting syndicate for smart-ring maker Oura's IPO, marking its first official underwriting role. While this move could enhance retail IPO allocations and support customer engagement, Robinhood appears positioned near the bottom of the syndicate, suggesting modest initial economics. Analysts view underwriting as a diversification effort rather than a material near-term growth driver.

Canadian Tariffs Hit $20B in U.S. Imports

Canada has implemented retaliatory tariffs of 15-50% on $20 billion worth of U.S. goods including metals, apparel, and milk, in response to recent U.S. tariffs on Canadian imports. The trade escalation has pressured pre-market futures across major indexes, with the Dow down 472 points. Markets await Friday's CPI inflation report, expected to show headline inflation at +3.4% and core inflation at +2.4%, as investors monitor geopolitical tensions affecting oil prices.

Bronstein, Gewirtz & Grossman LLC Urges Blaize Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Blaize Holdings, Inc. (NASDAQ: BZAI) alleging that the company made materially false statements and failed to disclose material adverse facts. The complaint claims Blaize announced transactions with unequipped entities to create false growth appearance, improperly recognized revenue, and made misleading statements about its business operations and prospects. Investors who purchased Blaize securities between July 18, 2025 and April 28, 2026 are encouraged to join the case, with a lead plaintiff deadline of October 5, 2026.

As Winter Approaches, Midea Helps Canadian Homeowners Rethink Heating System Replacements

Midea highlights how modern inverter-driven cold-climate heat pumps and dual-fuel systems provide Canadian homeowners with flexible alternatives to aging HVAC equipment. The company emphasizes that dual-fuel configurations allow homeowners to pair electric heat pumps with existing gas furnaces, reducing installation barriers. Midea's EVOX heat pump line delivers full heating output down to -35°C and operates continuously to -40°C, addressing historical concerns about heat pump performance in cold climates. The article also outlines available federal and provincial incentive programs to support heating system upgrades.

Bronstein, Gewirtz & Grossman LLC Urges Rackspace Technology, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Rackspace Technology, Inc. alleging that company executives made materially false and misleading statements regarding the company's business operations and financial condition during the period of May 7, 2026 to July 8, 2026. The complaint claims Rackspace failed to disclose declining Public Cloud revenue, the need to redirect resources from its profitable Private Cloud segment to enterprise AI efforts, and the resulting impact on fiscal year 2026 revenue.

Bronstein, Gewirtz & Grossman LLC Urges EquipmentShare.com Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against EquipmentShare.com Inc. (NASDAQ: EQPT) alleging that the company and its officers made materially false statements and failed to disclose undisclosed related-party transactions with entities owned by co-founders. The complaint claims the company's financial statements were misleading regarding these transactions. Investors who purchased securities during the IPO on January 23, 2026, or between January 23 and June 23, 2026, are eligible to join the case, with a lead plaintiff deadline of September 21, 2026.

Bronstein, Gewirtz & Grossman LLC Urges Fractyl Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Fractyl Health, Inc. (NASDAQ: GUTS) alleging that company executives made materially false and misleading statements regarding the effectiveness of its Revita product and the integrity of clinical trial results. The lawsuit covers investors who purchased Fractyl securities between January 13, 2025 and January 29, 2026. The lead plaintiff deadline is October 20, 2026.

Bronstein, Gewirtz & Grossman LLC Urges Intuit Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Intuit Inc. alleging that the company made materially false and misleading statements regarding its business operations and prospects during the period from August 22, 2025 to May 20, 2026. The complaint claims Intuit overstated its competitive advantages and growth while concealing significant business losses in its TurboTax division due to competitive and pricing pressures, rendering its FY 2026 revenue guidance unreliable.

Why Intel Stock Rallied Tuesday Morning

Intel stock surged 8-9% on reports of planned 10% CPU price increases aimed at improving gross margins. Northland Securities upgraded Intel to 'outperform' with a $120 price target, citing material progress in the company's turnaround and foundry ambitions. However, analysts note the stock is already expensive at 68x forward earnings.

Why D-Wave Quantum Stock Popped Today

D-Wave Quantum received up to $100 million in funding from the U.S. Department of Commerce under the CHIPS and Science Act, causing its stock to rise 10.86%. However, the government also awarded similar $100 million grants to rival quantum companies Quantinuum and Rigetti Computing. GlobalFoundries received the largest award at $375 million, suggesting it may be the government's preferred champion rather than D-Wave.

History Shows the Investors Who Make This 1 Move During Bear Markets Build the Most Wealth

The article argues that investors who aggressively buy during bear markets, rather than panic selling, build significantly more wealth over time. Using Warren Buffett's philosophy of maintaining cash reserves to deploy during market downturns, the piece demonstrates that a modest improvement in annual returns (from 10% to 11%) through strategic bear market investing could result in approximately one-third more wealth over 30 years. The key is maintaining discipline and a long-term perspective rather than attempting to time market peaks and troughs perfectly.

If I Could Invest $500 in Just 1 ETF in September, Here's What I'd Buy

A Motley Fool analyst recommends the Vanguard Total International Stock ETF (VXUS) as a single $500 investment choice for September 2026, citing concerns about S&P 500 valuations driven by AI stocks. VXUS has delivered 26% returns over the past year and 19.8% annualized returns over three years. Vanguard research forecasts international stocks may outperform U.S. stocks by 1.2-2.2% annually over the next 30 years.

Bronstein, Gewirtz & Grossman LLC Urges Papa John's International, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Papa John's International, Inc. (NASDAQ: PZZA) alleging securities fraud. The complaint claims that company executives made materially false and misleading statements regarding the company's transformation efforts, market share losses, and competitive position during the period from August 7, 2025 to August 5, 2026. Investors who purchased Papa John's securities during this period are encouraged to join the case, with a lead plaintiff deadline of November 2, 2026.

Bronstein, Gewirtz & Grossman LLC Urges iTonic Holdings Ltd. f/k/a Pheton Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against iTonic Holdings Ltd. (formerly Pheton Holdings Ltd.) alleging that the company made materially false and misleading statements regarding market manipulation schemes, fraudulent trading activity, and stock price inflation. The lawsuit covers investors who purchased shares between September 5, 2024 and July 29, 2025. The lead plaintiff deadline is September 29, 2026.

US Strategic Petroleum Reserve Crude Stocks Fall About 1.2M Barrels To 285.4M Barrels, Lowest Since 1982

Citigroup Initiates Coverage On UiPath with Buy Rating, Announces Price Target of $23

Citigroup analyst Yitchuin Wong initiates coverage on UiPath (NYSE:PATH) with a Buy rating and announces Price Target of $23.

8-K filing — Federal Home Loan Bank of Cincinnati

Filed: 2026-09-08 AccNo: 0001326771-26-000145 Size: 456 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Citigroup Upgrades Old Dominion Freight Line to Buy, Lowers Price Target to $223

Citigroup analyst Ariel Rosa upgrades Old Dominion Freight Line (NASDAQ:ODFL) from Neutral to Buy and lowers the price target from $231 to $223.

Citigroup Upgrades C.H. Robinson Worldwide to Buy, Lowers Price Target to $185

Citigroup analyst Ariel Rosa upgrades C.H. Robinson Worldwide (NASDAQ:CHRW) from Neutral to Buy and lowers the price target from $196 to $185.

Shares of medical device-related companies are trading lower amid possible sympathy with Boston Scientific after that company announced it was likely to miss its FY26 and Q3 adjusted EPS and net sales growth guidance following a previously announced cybersecurity incident that affected operations.

Why Guidewire Stock Dropped After Reporting An Upbeat Quarter

The Guidewire stock drop hit 20% after a Q4 earnings beat. See why soft FY27 guidance and a stretched valuation triggered the sell-off.

Citigroup Initiates Coverage On Arrowhead Pharma with Buy Rating, Announces Price Target of $108

Citigroup analyst Eric Joseph initiates coverage on Arrowhead Pharma (NASDAQ:ARWR) with a Buy rating and announces Price Target of $108.

8-K filing — iQSTEL Inc (IQST)

Filed: 2026-09-08 AccNo: 0001663577-26-000262 Size: 280 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Netflix Faces South Africa Price Probe, Putting Stock Under Pressure

Crude Oil Gains 1.5%; ABM Posts Upbeat Q3 Earnings

Ladenburg Thalmann Initiates Coverage On Evolv Technologies with Buy Rating, Announces Price Target of $8